BioPharma Dive

Building a robust in-process testing plan for cell therapy manufacturing success

Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...
GEN

Cell Therapy Manufacturing: Time to Move Fast

Emily Whitehead made the history books in 2012 when she become the first pediatric patient with B-cell acute lymphoblastic leukemia to be given a chimeric antigen receptor (CAR) T-cell therapy. After ...
GEN

Overcoming Cell Therapy CMC Challenges

No two batches of cell therapy are identical, because each is made from a different originator cell. For process development scientists tasked with ensuring product quality, this lack of consistency ...
ascopubs.org

Example of a simple and scalable manufacturing process for immunomodulatory alpha neutrophils, a specifically designed immuno-cell therapy with direct and indirect anti-cancer ...

Addition of IL-6 and phosphate to the m-EASIX score and detection of ICANS and CRS progression. A first-in-human study to evaluate a personalized neoantigen-based mRNA-loaded dendritic cell vaccine, ...
BioPharma Dive

The crucial role of raw material selection for success in cell therapy manufacturing

Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...
Business Wire

PHC Unveils Prototype of LiCellGrow, New Cell Expansion System to Support Development of Cell and Gene Therapy Products Manufacturing Process

TOKYO--(BUSINESS WIRE)--PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as "Biomedical Division") will showcase a prototype ...
News Medical

Building Bridges to Scalable Allogeneic Cell Therapy

Ahead of his talk at the 7th Annual Allogeneic Cell Therapies Summit, Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and large-scale ...